메뉴 건너뛰기




Volumn 12, Issue 5, 2013, Pages 567-576

A novel antiandrogen, compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth In Vitro and In Vivo

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; COMPOUND 30; ENZALUTAMIDE; METRIBOLONE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

EID: 84877686260     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-12-0798     Document Type: Article
Times cited : (87)

References (31)
  • 2
  • 4
    • 58949101975 scopus 로고    scopus 로고
    • In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors
    • Snoek R, Cheng H, Margiotti K, Wafa LA, Wong CA, Wong EC, et al. In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors. Clin Cancer Res 2009;15:39-47.
    • (2009) Clin Cancer Res , vol.15 , pp. 39-47
    • Snoek, R.1    Cheng, H.2    Margiotti, K.3    Wafa, L.A.4    Wong, C.A.5    Wong, E.C.6
  • 5
    • 65549168746 scopus 로고    scopus 로고
    • Anovel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth
    • Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, et al. Anovel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res 2009;69:2305-13.
    • (2009) Cancer Res , vol.69 , pp. 2305-2313
    • Guo, Z.1    Yang, X.2    Sun, F.3    Jiang, R.4    Linn, D.E.5    Chen, H.6
  • 6
    • 79960979238 scopus 로고    scopus 로고
    • Increased androgen receptor transcription: A cause of castration-resistant prostate cancer and a possible therapeutic target
    • Shiota M, Yokomizo A, Naito S. Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target. J Mol Endocrinol 2011;47: R25-41.
    • (2011) J Mol Endocrinol , vol.47
    • Shiota, M.1    Yokomizo, A.2    Naito, S.3
  • 7
    • 77955296562 scopus 로고    scopus 로고
    • Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
    • Sun S, Sprenger CC, Vessella RL, Haugk K, Soriano K, Mostaghel EA, et al. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. J Clin Invest 2010;120:2715-30.
    • (2010) J Clin Invest , vol.120 , pp. 2715-2730
    • Sun, S.1    Sprenger, C.C.2    Vessella, R.L.3    Haugk, K.4    Soriano, K.5    Mostaghel, E.A.6
  • 8
    • 51049098138 scopus 로고    scopus 로고
    • Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
    • Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, et al. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res 2008;68:6407-15.
    • (2008) Cancer Res , vol.68 , pp. 6407-6415
    • Locke, J.A.1    Guns, E.S.2    Lubik, A.A.3    Adomat, H.H.4    Hendy, S.C.5    Wood, C.A.6
  • 9
    • 0035496220 scopus 로고    scopus 로고
    • The development of androgen-independent prostate cancer
    • Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45.
    • (2001) Nat Rev Cancer , vol.1 , pp. 34-45
    • Feldman, B.J.1    Feldman, D.2
  • 10
    • 4944246790 scopus 로고    scopus 로고
    • Targeting the androgen receptor: Improving outcomes for castration-resistant prostate cancer
    • Scher HI, Buchanan G, Gerald W, Butler LM, Tilley WD. Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr Relat Cancer 2004;11:459-76.
    • (2004) Endocr Relat Cancer , vol.11 , pp. 459-476
    • Scher, H.I.1    Buchanan, G.2    Gerald, W.3    Butler, L.M.4    Tilley, W.D.5
  • 11
    • 65649090203 scopus 로고    scopus 로고
    • Development of a second-generation antiandrogen for treatment of advanced prostate cancer
    • Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science 2009;324:787-90.
    • (2009) Science , vol.324 , pp. 787-790
    • Tran, C.1    Ouk, S.2    Clegg, N.J.3    Chen, Y.4    Watson, P.A.5    Arora, V.6
  • 12
    • 77952105685 scopus 로고    scopus 로고
    • Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study
    • Scher HI, Beer TM, Higano CS, Anand A, Taplin ME, Efstathiou E, et al. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Lancet 2010;375:1437-46.
    • (2010) Lancet , vol.375 , pp. 1437-1446
    • Scher, H.I.1    Beer, T.M.2    Higano, C.S.3    Anand, A.4    Taplin, M.E.5    Efstathiou, E.6
  • 15
    • 80455162581 scopus 로고    scopus 로고
    • Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists
    • Guo C, Linton A, Kephart S, Ornelas M, Pairish M, Gonzalez J, et al. Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists. J Med Chem 2011;54:7693-704.
    • (2011) J Med Chem , vol.54 , pp. 7693-7704
    • Guo, C.1    Linton, A.2    Kephart, S.3    Ornelas, M.4    Pairish, M.5    Gonzalez, J.6
  • 16
    • 0038756444 scopus 로고    scopus 로고
    • Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors
    • Kiyama S, Morrison K, Zellweger T, Akbari M, Cox M, Yu D, et al. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Cancer Res 2003;63:3575-84.
    • (2003) Cancer Res , vol.63 , pp. 3575-3584
    • Kiyama, S.1    Morrison, K.2    Zellweger, T.3    Akbari, M.4    Cox, M.5    Yu, D.6
  • 17
    • 79954624502 scopus 로고    scopus 로고
    • A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis
    • Lamoureux F, Thomas C, Yin MJ, Kuruma H, Fazli L, Gleave ME, et al. A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis. Clin Cancer Res 2011;17:2301-13.
    • (2011) Clin Cancer Res , vol.17 , pp. 2301-2313
    • Lamoureux, F.1    Thomas, C.2    Yin, M.J.3    Kuruma, H.4    Fazli, L.5    Gleave, M.E.6
  • 18
    • 35948950583 scopus 로고    scopus 로고
    • Cooperative interactions between androgen receptor (AR) and heatshock protein 27 facilitate AR transcriptional activity
    • Zoubeidi A, Zardan A, Beraldi E, Fazli L, Sowery R, Rennie P, et al. Cooperative interactions between androgen receptor (AR) and heatshock protein 27 facilitate AR transcriptional activity. Cancer Res 2007;67:10455-65.
    • (2007) Cancer Res , vol.67 , pp. 10455-10465
    • Zoubeidi, A.1    Zardan, A.2    Beraldi, E.3    Fazli, L.4    Sowery, R.5    Rennie, P.6
  • 19
    • 0026602518 scopus 로고
    • Serum prostate specific antigen levels in mice bearinghuman prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors
    • Gleave ME, Hsieh JT, Wu HC, von Eschenbach AC, Chung LW. Serum prostate specific antigen levels in mice bearinghuman prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res 1992;52:1598-605.
    • (1992) Cancer Res , vol.52 , pp. 1598-1605
    • Gleave, M.E.1    Hsieh, J.T.2    Wu, H.C.3    Von Eschenbach, A.C.4    Chung, L.W.5
  • 20
    • 70349395222 scopus 로고    scopus 로고
    • Anti-androgens and androgen-depleting therapies in prostate cancer: New agents for an established target
    • Chen Y, Clegg NJ, Scher HI. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target. Lancet Oncol 2009;10:981-91.
    • (2009) Lancet Oncol , vol.10 , pp. 981-991
    • Chen, Y.1    Clegg, N.J.2    Scher, H.I.3
  • 22
    • 1542574202 scopus 로고    scopus 로고
    • Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    • Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, et al. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 2004;164: 217-27.
    • (2004) Am J Pathol , vol.164 , pp. 217-227
    • Holzbeierlein, J.1    Lal, P.2    Latulippe, E.3    Smith, A.4    Satagopan, J.5    Zhang, L.6
  • 23
    • 33645056171 scopus 로고    scopus 로고
    • Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
    • Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006;66:2815-25.
    • (2006) Cancer Res , vol.66 , pp. 2815-2825
    • Stanbrough, M.1    Bubley, G.J.2    Ross, K.3    Golub, T.R.4    Rubin, M.A.5    Penning, T.M.6
  • 25
    • 0042978480 scopus 로고    scopus 로고
    • Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
    • Edwards J, Krishna NS, Grigor KM, Bartlett JM. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer 2003;89:552-6.
    • (2003) Br J Cancer , vol.89 , pp. 552-556
    • Edwards, J.1    Krishna, N.S.2    Grigor, K.M.3    Bartlett, J.M.4
  • 26
    • 0036170838 scopus 로고    scopus 로고
    • Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells
    • Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002;62:1008-13.
    • (2002) Cancer Res , vol.62 , pp. 1008-1013
    • Zegarra-Moro, O.L.1    Schmidt, L.J.2    Huang, H.3    Tindall, D.J.4
  • 27
    • 79960277488 scopus 로고    scopus 로고
    • Prostate cancer: Abiraterone increases overall survival in men with castration-resistant prostate cancer
    • Fenner A. Prostate cancer: abiraterone increases overall survival in men with castration-resistant prostate cancer. Nat Rev Urol 2011;8:351.
    • (2011) Nat Rev Urol , vol.8 , pp. 351
    • Fenner, A.1
  • 28
    • 77950267783 scopus 로고    scopus 로고
    • Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD
    • Zoubeidi A, Zardan A, Wiedmann RM, Locke J, Beraldi E, Fazli L, et al. Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD. Cancer Res 2010;70:2307-17.
    • (2010) Cancer Res , vol.70 , pp. 2307-2317
    • Zoubeidi, A.1    Zardan, A.2    Wiedmann, R.M.3    Locke, J.4    Beraldi, E.5    Fazli, L.6
  • 29
    • 80052256577 scopus 로고    scopus 로고
    • Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate resistant prostate cancer
    • Lamoureux F, Thomas C, Yin MJ, Kuruma H, Beraldi E, Fazli L, et al. Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate resistant prostate cancer. Cancer Res 2011;71:5838-49.
    • (2011) Cancer Res , vol.71 , pp. 5838-5849
    • Lamoureux, F.1    Thomas, C.2    Yin, M.J.3    Kuruma, H.4    Beraldi, E.5    Fazli, L.6
  • 30
    • 25844519550 scopus 로고    scopus 로고
    • HSP90 and the chaperoning of cancer
    • Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005;5:761-72.
    • (2005) Nat Rev Cancer , vol.5 , pp. 761-772
    • Whitesell, L.1    Lindquist, S.L.2
  • 31
    • 79955866277 scopus 로고    scopus 로고
    • Current clinical trials in castrate-resistant prostate cancer
    • Petrylak DP. Current clinical trials in castrate-resistant prostate cancer. Curr Urol Rep 2011;12:173-9.
    • (2011) Curr Urol Rep , vol.12 , pp. 173-179
    • Petrylak, D.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.